Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 2 | -2.35M | 100% | $4.16 | -$9.78M |
Net | -2 | -2.35M | -100% | -$9.78M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Orbimed Advisors Llc | Director, 10%+ Owner | $29.8M | -$4.89M | -14.1% | Jun 27, 2025 |
Peter A. Thompson | Director, 10%+ Owner | $29.8M | -$4.89M | -14.1% | Jun 27, 2025 |
Adams Street Partners Llc | 10%+ Owner | $8.03M | Aug 11, 2022 | ||
Richard A. Miller | President and CEO, Director | $7.44M | May 7, 2025 | ||
Terry P. Gould | Director, 10%+ Owner | $5.67M | Jun 13, 2024 | ||
William Benton Jones | SVP, Pharmaceutical Development | $606K | Jun 4, 2025 | ||
EcoR1 Capital, LLC | 10%+ Owner | $199K | Sep 30, 2021 | ||
Scott W. Morrison | Director | Jun 12, 2025 | |||
Richard van den Broek | Director | Apr 8, 2025 | |||
Ian T. Clark | Director | Jun 12, 2025 | |||
Jeffrey Arcara | Chief Business Officer | Dec 20, 2024 | |||
Leiv Lea | Chief Financial Officer | Dec 20, 2024 | |||
Linda Grais | Director | Jun 12, 2025 | |||
Edith P. Mitchell | Director | Dec 6, 2023 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|